An observational study in Squamous Cell Carcinoma of the Anal Canal and HPV-induced Cancer, sponsored by Centre Hospitalier Intercommunal Creteil. Recruiting at 32 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-01.
Sponsored by Centre Hospitalier Intercommunal Creteil · Observational
This study examines care pathways in 300 patients with anal squamous cell carcinoma to identify barriers and delays in diagnosis, assess the impact of screening and access to care, and improve awareness, screening practices, and early diagnosis.
This situational analysis will make it possible to identify barriers and delays in diagnosis, to assess waiting times for access to consultations, and to evaluate the existence of potential fast-track diagnostic pathways.
It will analyze the proportion of cancers diagnosed through screening as well as the proportion of eligible patients who did not benefit from screening.
Assessing patient reluctance, the impact of socio-economic conditions, and patients' knowledge of the link between HPV and anal cancer will help better target public information efforts.
Ultimately, the aim of the study is to improve care pathways in order to enhance public and healthcare professional awareness and promote earlier diagnosis.
Centre Hospitalier Intercommunal Creteil is the lead sponsor of 131 studies on the registry; 36 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients diagnosed with squamous cell carcinoma of the anal canal
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Having read and understood the information letter provided, either:
i. After disclosure of the diagnosis, or ii. At the latest 6 months after initiation of treatment (surgical excision, radiotherapy, or chemoradiotherapy)
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).
Your pathology report is the document that shows this.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Histologically or cytologically confirmed
The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).
Your pathology report is the document that shows this.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adult patients diagnosed with histologically confirmed anal squamous cell carcinoma.
Other: self-administered questionnaire
Completion of a self-administered questionnaire by the patient to collect information about their care journey, any difficulties or hesitations, as well as their knowledge of the link between papillomavirus and cancer.
First symptom(s) and the histological diagnosis
Time between the first symptom(s) and the histological diagnosis of anal squamous cell carcinoma.
Time frame: At the inclusion
Primary tumor, regional nodes, metastasis (TNM) ) stage comparison
Comparison of diagnostic stages and patient pathways according to whether or not they underwent scr
Time frame: At the inclusion
Assessment of Deprivation and Health Inequalities for Health Examination Centers, French
French public-health index used to assess an individual's level of social and material deprivation based on living conditions, financial situation, social support, and access to healthcare. It helps identify social health inequalities and adapt medical care accordingly. \[0 to 100\], The higher the score → the greater the level of deprivation.
Time frame: At the inclusion
Link between HPV and anal cancer
Proportion of patients aware of the link between HPV and anal cancer
Time frame: At the inclusion
Performing a rectal examination at the first consultation
Assess the proportion of patients who underwent a clinical examination with rectal examination at the first consultation
Time frame: At the inclusion
Started Jun 2026 (actual). Primary completion is estimated for Sep 2028, 27 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Intercommunal Creteil →